Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
23%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
GDOC
39
HOLDINGS
16%
ALSO IN HART
HART
75
HOLDINGS
9%
ALSO IN GDOC
SECTOR DRIFT (GDOC minus HART)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GDOC |
Weight in HART |
Overlap | |
---|---|---|---|---|
BOSTON SCIENTIFIC CORP | 9.0% | 5.8% | 5.8% | |
ABBOTT LABORATORIES | 5.1% | 5.5% | 5.1% | |
ELI LILLY & CO | 8.1% | 4.5% | 4.5% | |
ASTRAZENECA PLC | 4.4% | 5.9% | 4.4% | |
NOVO NORDISK A/S-B | 2.4% | 2.5% | 2.4% |
GDOC Overweight Relative to HART
ABBVIE INC | 6.3% | |
INSULET CORP | 6.1% | |
INTUITIVE SURGICAL INC | 5.2% | |
ELI LILLY & CO | 3.7% | |
MERCK & CO. INC. | 3.6% | |
UNITEDHEALTH GROUP INC | 3.3% | |
LONZA GROUP AG-REG | 3.2% | |
BOSTON SCIENTIFIC CORP | 3.2% | |
ALNYLAM PHARMACEUTICALS INC | 3.2% | |
COOPER COS INC/THE | 3.0% |
GDOC Underweight Relative to HART
ALPHABET INC. CLASS A | -6.8% | |
NOVARTIS AG | -6.0% | |
JOHNSON & JOHNSON | -5.6% | |
MEDTRONIC PLC | -5.3% | |
APPLE INC | -4.9% | |
PFIZER INC | -4.7% | |
BRISTOL-MYERS SQUIBB CO | -3.9% | |
SANOFI-AVENTIS | -3.2% | |
NIKE INC -CL B | -2.6% | |
HCA HOLDINGS INC | -2.3% |